ebulization with 3% hypertonic saline vs adrenaline in Acute bronchiolitis
Not Applicable
- Conditions
- Health Condition 1: J219- Acute bronchiolitis, unspecified
- Registration Number
- CTRI/2023/05/052255
- Lead Sponsor
- Dr. Anupama Singh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children with a chronological age of 2 months to 24 months, a clinical diagnosis of bronchiolitis and their initial Wang respiratory score will be 3 or higher will be included in study
Exclusion Criteria
1.Patients not giving consent.
2.Children with prior illness with wheezing will be excluded.
3.Children with prior use of bronchodilators.
4.Premature infants ( <34 weeks of gestation).
5.Children with congenital heart disease.
6.Children with chronic lung disease
7.Severe bronchiolitis (either wang score >9 or baseline oxygen saturation <85%)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1)Efficacy of 3% hypertonic saline vs Nebulised Adrenaline <br/ ><br>2)Safety of 3% hypertonic saline vs Nebulised AdrenalineTimepoint: Monitoring parameters for improvement or worsening of the condition will be measured and recorded on admission and then at 24 hours,48 hours and 72 hours of admission using the clinical score described by Wang et al. <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1) Changes in clinical scoring <br/ ><br>2)Duration of hospitalizationTimepoint: 1) at the time of admission then at 24 hours,48 hours and then at 72 hours of admission <br/ ><br>2) Number of days child was admitted